TuHURA Biosciences Inc (HURA)

Currency in USD
2.3000
-0.1300(-5.35%)
Closed·
After Hours
2.3400+0.0400(+1.74%)
·
HURA Scorecard
Full Analysis
2 analysts have revised their earnings downwards for the upcoming period
HURA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.29002.4623
52 wk Range
1.80008.6345
Key Statistics
Prev. Close
2.43
Open
2.43
Day's Range
2.29-2.4623
52 wk Range
1.8-8.6345
Volume
134.28K
Average Volume (3m)
263.44K
1-Year Change
-62.17%
Book Value / Share
0.22
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
HURA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
12.0833
Upside
+425.36%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

TuHURA Biosciences Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

TuHURA Biosciences Inc Company Profile

TuHURA Biosciences, Inc., a clinical stage immuno-oncology company, that develops novel technologies for the treatment of cancer immunotherapies. The company’s lead product candidate includes IFx2.0, an innate immune agonist designed to overcome primary resistance to checkpoint inhibitors. It is also preparing to initiate a single randomized placebo-controlled which is in Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda; and Delta receptor technology to develop tumor microenvironment modulators in the form of first-in-class bi-specific antibody-peptide conjugates and antibody-drug conjugates targeting Myeloid Derived Suppressor Cells. In addition, the company is also developing Immune Fx; IFx-3.0, an mRNA innate immune agonist candidate for intravenous or autologous whole cell administration for blood-related cancers. The company was formerly known as Morphogenesis, Inc. and changed its name to TuHURA Biosciences, Inc. in December 2023. The company was founded in 1995 and is based in Tampa, Florida. TuHURA Biosciences, Inc. operates as a subsidiary of CohBar, Inc.

Compare HURA to Peers and Sector

Metrics to compare
HURA
Peers
Sector
Relationship
P/E Ratio
−4.4x−3.0x−0.5x
PEG Ratio
-−0.060.00
Price/Book
11.2x2.0x2.6x
Price / LTM Sales
-9.5x3.3x
Upside (Analyst Target)
-205.7%43.5%
Fair Value Upside
Unlock6.6%6.8%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 12.0833
(+425.36% Upside)

Earnings

Latest Release
May 15, 2025
EPS / Forecast
-0.15 / -0.17
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

HURA Income Statement

People Also Watch

18.23
SRPT
+1.50%
4.130
ATAI
-0.48%
2.56
INMB
-8.24%
5.29
REPL
-3.47%
0.547
WINT
-6.81%

FAQ

What Stock Exchange Does TuHURA Biosciences Trade On?

TuHURA Biosciences is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for TuHURA Biosciences?

The stock symbol for TuHURA Biosciences is "HURA."

What Is the TuHURA Biosciences Market Cap?

As of today, TuHURA Biosciences market cap is 107.06M.

What Is TuHURA Biosciences's Earnings Per Share (TTM)?

The TuHURA Biosciences EPS (TTM) is -0.92.

From a Technical Analysis Perspective, Is HURA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has TuHURA Biosciences Stock Split?

TuHURA Biosciences has split 5 times.

How Many Employees Does TuHURA Biosciences Have?

TuHURA Biosciences has 3 employees.

What is the current trading status of TuHURA Biosciences (HURA)?

As of 10 Aug 2025, TuHURA Biosciences (HURA) is trading at a price of 2.30, with a previous close of 2.43. The stock has fluctuated within a day range of 2.29 to 2.46, while its 52-week range spans from 1.80 to 8.63.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.